Cargando…

Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease

Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials. In this study, we investigated the mechanisms of Qing-Re-Xiao-Zheng-Yi-Qi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qiaoru, Yan, Runze, Yang, Hanwen, Wang, Yixuan, Zhang, Chao, Zhang, Jiale, Cui, Zhaoli, Wang, Yaoxian, Sun, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807870/
https://www.ncbi.nlm.nih.gov/pubmed/36605399
http://dx.doi.org/10.3389/fphar.2022.992597
_version_ 1784862807019225088
author Wu, Qiaoru
Yan, Runze
Yang, Hanwen
Wang, Yixuan
Zhang, Chao
Zhang, Jiale
Cui, Zhaoli
Wang, Yaoxian
Sun, Weiwei
author_facet Wu, Qiaoru
Yan, Runze
Yang, Hanwen
Wang, Yixuan
Zhang, Chao
Zhang, Jiale
Cui, Zhaoli
Wang, Yaoxian
Sun, Weiwei
author_sort Wu, Qiaoru
collection PubMed
description Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials. In this study, we investigated the mechanisms of Qing-Re-Xiao-Zheng-Yi-Qi Formula in the treatment of diabetic kidney disease. Methods: We used Vanquish UHPLC(TM) to analyze the chemical profiling of Qing-Re-Xiao-Zheng-Yi-Qi Formula freeze-dried powder. We constructed diabetic kidney disease rat models induced by unilateral nephrectomy and high-dose streptozocin injection. We examined blood urea nitrogen, serum creatinine, serum glucose, total cholesterol, triglyceride, serum total protein, albumin, alanine aminotransferase, aspartate aminotransferase and 24 h urinary total protein in diabetic kidney disease rats. The renal pathological changes were observed by HE, Masson, PAS stanning and transmission electron microscopy. The levels of fibrosis-related proteins and mitophagy-related proteins were detected by western blot analysis. We also conducted an immunofluorescence co-localization analysis on podocytes to further investigate the effect of Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment on mitophagy. Results: A total of 27 constituents in Qing-Re-Xiao-Zheng-Yi-Qi Formula were tentatively identified. We found PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could raise body weight and reduce renal index, reduce proteinuria, improve glycolipid metabolic disorders, ameliorate renal fibrosis, and reduce the expression of Col Ⅳ and TGF-β1 in diabetic kidney disease rats. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could also increase the expression of nephrin, activate mitophagy and protect podocytes in diabetic kidney disease rats and high glucose cultured podocytes. Conclusion: PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease, and Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could not only ameliorate pathological damage, but also promote mitophagy to protect podocytes in diabetic kidney disease.
format Online
Article
Text
id pubmed-9807870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98078702023-01-04 Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease Wu, Qiaoru Yan, Runze Yang, Hanwen Wang, Yixuan Zhang, Chao Zhang, Jiale Cui, Zhaoli Wang, Yaoxian Sun, Weiwei Front Pharmacol Pharmacology Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials. In this study, we investigated the mechanisms of Qing-Re-Xiao-Zheng-Yi-Qi Formula in the treatment of diabetic kidney disease. Methods: We used Vanquish UHPLC(TM) to analyze the chemical profiling of Qing-Re-Xiao-Zheng-Yi-Qi Formula freeze-dried powder. We constructed diabetic kidney disease rat models induced by unilateral nephrectomy and high-dose streptozocin injection. We examined blood urea nitrogen, serum creatinine, serum glucose, total cholesterol, triglyceride, serum total protein, albumin, alanine aminotransferase, aspartate aminotransferase and 24 h urinary total protein in diabetic kidney disease rats. The renal pathological changes were observed by HE, Masson, PAS stanning and transmission electron microscopy. The levels of fibrosis-related proteins and mitophagy-related proteins were detected by western blot analysis. We also conducted an immunofluorescence co-localization analysis on podocytes to further investigate the effect of Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment on mitophagy. Results: A total of 27 constituents in Qing-Re-Xiao-Zheng-Yi-Qi Formula were tentatively identified. We found PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could raise body weight and reduce renal index, reduce proteinuria, improve glycolipid metabolic disorders, ameliorate renal fibrosis, and reduce the expression of Col Ⅳ and TGF-β1 in diabetic kidney disease rats. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could also increase the expression of nephrin, activate mitophagy and protect podocytes in diabetic kidney disease rats and high glucose cultured podocytes. Conclusion: PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease, and Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could not only ameliorate pathological damage, but also promote mitophagy to protect podocytes in diabetic kidney disease. Frontiers Media S.A. 2022-12-20 /pmc/articles/PMC9807870/ /pubmed/36605399 http://dx.doi.org/10.3389/fphar.2022.992597 Text en Copyright © 2022 Wu, Yan, Yang, Wang, Zhang, Zhang, Cui, Wang and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wu, Qiaoru
Yan, Runze
Yang, Hanwen
Wang, Yixuan
Zhang, Chao
Zhang, Jiale
Cui, Zhaoli
Wang, Yaoxian
Sun, Weiwei
Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
title Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
title_full Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
title_fullStr Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
title_full_unstemmed Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
title_short Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
title_sort qing-re-xiao-zheng-yi-qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807870/
https://www.ncbi.nlm.nih.gov/pubmed/36605399
http://dx.doi.org/10.3389/fphar.2022.992597
work_keys_str_mv AT wuqiaoru qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT yanrunze qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT yanghanwen qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT wangyixuan qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT zhangchao qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT zhangjiale qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT cuizhaoli qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT wangyaoxian qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease
AT sunweiwei qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease